Cyclerion Therapeutics, Inc.

Nasdaq:CYCN

Pharmaceutical Preparations·CAMBRIDGE, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-K/A	FY 2024	12/31/24	11/12/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	3/4/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
5/12/23	Q2 FY2023	→
3/22/23	Q1 FY2023	→
8/9/22	Q3 FY2022	→
5/4/22	Q2 FY2022	→
2/24/22	Q1 FY2022	→
11/9/21	Q4 FY2021	→
↓

News (8-K)

51 shown

Filed	Type	Description
2/17/26	Reg FD	Regulation FD Disclosure	→
1/6/26	Agreement	Entry into a Material Definitive Agreement	→
12/1/25	Other	Other Events	→
9/23/25	Agreement	Entry into a Material Definitive Agreement	→
6/18/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/7/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

18 shown

Filed	Form	Description
5/7/25	424B5	424B5	→
5/6/25	S-3	S-3	→
2/4/25	S-3	S-3	→
7/31/23	S-8	S-8	→
8/10/22	S-8	S-8	→
7/30/21	S-8	S-8	→
↓

Filing History(337 filings)

TypeDateAccessionPeriodSize

8-K

Feb 17, 2026

0001193125-26-0530358-K

Feb 17, 2026

180.0 KB

8-K

Jan 6, 2026

0001193125-26-0035098-K

Jan 3, 2026

8.3 MB

8-K

Dec 1, 2025

0001193125-25-3040678-K

Dec 1, 2025

134.2 KB

10-Q

Nov 12, 2025

0001193125-25-27774910-Q

Sep 30, 2025

6.4 MB

10-K/A

Nov 12, 2025

0001193125-25-27762110-K/A

Dec 31, 2024

8.5 MB

SCHEDULE 13G

Oct 17, 2025

0001493152-25-018450

—

17.1 KB

8-K

Sep 23, 2025

0001193125-25-2133328-K

Sep 19, 2025

5.4 MB

SCHEDULE 13G/A

Aug 14, 2025

0001641172-25-024017

—

7.3 KB

Aug 11, 2025

0000950170-25-1065324

Aug 7, 2025

5.5 KB

10-Q

Aug 5, 2025

0000950170-25-10312310-Q

Jun 30, 2025

5.7 MB

8-K

Jun 18, 2025

0001193125-25-1427658-K

Jun 16, 2025

156.8 KB

EFFECT

May 15, 2025

9999999995-25-001628

—

1.7 KB

SCHEDULE 13G/A

May 15, 2025

0001641172-25-010930

—

6.9 KB

CORRESP

May 13, 2025

0001193125-25-118816

—

6.8 KB

UPLOAD

May 12, 2025

0000000000-25-005035

—

39.1 KB

8-K

May 7, 2025

0001193125-25-1150898-K

May 7, 2025

407.6 KB

424B5

May 7, 2025

0001193125-25-115085424B5

—

350.5 KB

S-3

May 6, 2025

0001193125-25-113869S-3

—

333.7 KB

10-Q

May 6, 2025

0000950170-25-06449310-Q

Mar 31, 2025

5.1 MB

DEFA14A

Apr 29, 2025

0001140361-25-016374DEFA 14A

—

1.3 MB

DEF 14A

Apr 29, 2025

0001140361-25-016370DEF 14A

Jun 16, 2025

4.4 MB

SCHEDULE 13D/A

Mar 28, 2025

0000950170-25-047124

—

9.5 KB

Mar 27, 2025

0000950170-25-0462804

Mar 25, 2025

7.3 KB

Mar 27, 2025

0000950170-25-0460994

Mar 25, 2025

4.6 KB

8-K

Mar 25, 2025

0001193125-25-0626128-K

Mar 21, 2025

505.8 KB

25 filings shown

Cyclerion Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(337 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/29/25	DEFA14A	DEFA 14A	→
4/29/25	DEF 14A	DEF 14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
6/20/23	DEFM14A	DEFM14A	→
6/9/23	PREM14A	PREM14A	→
↓

Filed	Form	Description
8/11/25	4	4	→
3/27/25	4	4	→
3/27/25	4	4	→
11/25/24	4	4	→
8/7/24	4	4	→
7/12/24	SC 13G/A	SC 13G/A	→
↓

Filed	Form	Description
10/17/25	SCHEDULE 13G	SCHEDULE 13G	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	EFFECT	EFFECT	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/28/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/12/25	EFFECT	EFFECT	→
↓